The organization does not plan to release any additional information about the reasons for his departure.
The board of directors for 340B Health announced Thursday that Ted Slafsky would step down Thursday from his role as CEO of the association, leaving the organization without a CEO for the rest of March.
Maureen Testoni, former senior vice president and general counsel of 340B Health, will step in as interim president and CEO on April 1, the organization said in a brief statement.
In the meantime, Rob Miller, senior vice president of business development, strategic planning, and operations, will be the group’s highest-ranking leader, a spokesperson tells HealthLeaders Media.
Slafsky, who worked more than two decades with the organization, made the decision jointly with the board, a spokesperson said, declining to characterize the reasons for the sudden departure.
The spokesperson said 340B Health does not anticipate releasing any additional information about the situation.
Testoni, who will serve in an interim capacity while a search is conducted for a permanent replacement, previously worked seven years with 340B Health.
“Maureen is well known and respected in the 340B community and we are confident that she will successfully lead the organization during this transition,” the organization said in its statement.
The organization describes itself as an association of more than 1,300 hospitals that advocates for hospitals that participate in the 340B Drug Pricing Program.
Slafsky—who has been vocal in the ongoing fight against planned cuts to 340B federal funding—released a statement via email Thursday to HealthLeaders Media calling 340B Health "a great organization that I was fortunate to lead."
"I am confident it will continue to do an excellent job in representing the interests of the 340B hospital community," Slafsky wrote. "I have nothing but great memories and wish the organization, our members and staff my very best.”
His bio was removed from 340B Health's website.
This story has been updated to include Slafsky's statement.
Steven Porter is editor at HealthLeaders.